Return to Course LibraryCE InformationRegister NowAdd to Outlook


DaCarla M. Albright, MD
Associate Professor of Clinical Obstetrics & Gynecology
University of Pennsylvania


Emily F. Conant, MD
Division Chief, Breast Imaging
Professor of Radiology
University of Pennsylvania


Moderator, Nancy M. Cappello, PhD
Founder & Director
Are You Dense, Inc.
Are You Dense Advocacy, Inc.

 

A free one-hour interview with a radiologist & a gynecologist for family practice physicians, gynecologists, nurses, radiologists, & radiologic technologists
Available for CME, CNE, and CE credit

 

Talking Sense About Breast Density
A Conversation with a Radiologist & a Gynecologist

Tuesday|December 12, 2017
7:00 PM EASTERN|6:00 PM CENTRAL|5:00 PM MOUNTAIN|4:00 PM PACIFIC


Course Overview
Mammography continues to be the standard of care for breast cancer screening. However, not only can dense breast tissue mask breast cancer on mammography, breast density is an independent risk factor for developing breast cancer.

Legislative efforts by breast cancer patients have spearheaded a movement toward requiring mammography reports to include breast density information to patients. Today, more than half of the states in the U.S. have introduced or passed legislation requiring breast density patient notification. This patient awareness about the importance of breast density is necessitating new conversations between patients and their healthcare providers.

This course will educate primary caregivers about the associated risks of breast density, how best to counsel patients regarding breast cancer screening, and the imaging tools available for patients at risk.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

  • Explain the risks associated with having dense breast tissue and the four categories of breast density
  • In addition to available mammographic technologies, list supplemental breast screening modalities
  • Discuss current legislative efforts to inform patients about their breast density status
  • Counsel patients on their personal risk for developing breast cancer, the importance of annual screening, and the available options for screening for high-risk patients

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to http://www.uems.eu/uems-activities/accreditation/eaccme.

Nurse Continuing  Education
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This educational activity for 1.0 contact hour(s) is provided by the Postgraduate Institute for Medicine. 

Radiologic Technologist Continuing Medical Education
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

How to Enroll and Participate
This program is offered by ICPME through WebEx webinar service at no charge to the learner.

Credit cannot be granted for group viewing. To receive credit, each attendee must sign in on a separate computer.

  • Click ENROLL NOW and follow the registration instructions to register with ICPME.
  • You will receive an email from ICPME confirming your registration.
  • At the end of the registration process, click on ACCESS WEBINAR to complete the pre-course survey as well as to register on the ICPME WebEx site.
  • NOTE:  You must  ENROLL in this course on the www.icpme.us website as well as on the WebEx site.
  • Detailed log-in instructions will be sent to you via e-mail the day before the webinar.

How to Receive Credit

  • To receive credit, each participant must attend the entire session and complete the postcourse evaluation within 7 days after the presentation.

  • Upon verification of your participation from the WebEx event report, you will receive an email from ICPME two weeks after the event with instructions to print your certificate of credit. You will not be able to print your certificate until that time.

Your certificate of credit will remain in your account at www.icpme.us as a permanent record of your participation.


Faculty

From left to right: Emily F. Conant, MD, DaCarla M. Albright, MD,  and moderator Nancy M. Cappello, PhD, Founder & Director, Are You Dense, Inc., and Are You Dense Advocacy, Inc.


DaCarla M. Albright, MD
Dr. Albright is currently Associate Professor of Clinical Obstetrics and Gynecology at the University of Pennsylvania School of Medicine. She received her medical degree from University of Michigan Medical School, followed by a residency in Obstetrics and Gynecology at Sinai Hospital of Baltimore.

Dr. Albright is a member of the American Congress of Obstetricians and Gynecologists (ACOG) and the Association of Professors of Gynecology and Obstetrics (APGO).  Her academic interests are strongly focused in medical education, as the current Associate Clerkship Director for the Core Clinical Ob/Gyn Clerkship at the Perelman School of Medicine and Chair of the Undergraduate Medical Education Committee.  Clinically, she has a thriving practice as an academic generalist Obstetrician/Gynecologist, emphasizing wellness and prevention.  Dr. Albright has lectured on breast health and screening, with a desire to inform patients and colleagues of current screening guidelines and emerging screening modalities.

Emily F. Conant, MD
Dr. Conant is currently Division Chief, Breast Imaging and Professor of Radiology at the University of Pennsylvania. After attending medical school at the University of Pennsylvania School of Medicine, Dr. Conant went on to complete her residency in Diagnostic Radiology and then fellowship in thoracic and breast imaging at Penn. She began her career at Thomas Jefferson University Hospital and eight years later returned to Penn as Chief of Breast Imaging.

Dr. Conant, a pioneer in the development of digital mammography and digital breast tomosynthesis, is a leader in research on the use and benefits of early mammography screening and on the role of multimodality breast imaging. As an internationally known clinician and researcher, Dr. Conant has received grants from the National Institutes of Health to compare standard surgical biopsy with digital mammography and stereotactic core breast biopsy. She has published more than 150 peer-reviewed articles on topics ranging from novel imaging technologies; the assessment of disparities in access to imaging; and quantitative analysis of multimodality breast images to guide personalized screening. In addition to her clinical and research responsibilities, Dr. Conant continues to guide faculty governance and organizational change at the Perelman School of Medicine at Penn.

Dr. Conant is a fellow of the Society of Breast Imaging and a member of a multitude of professional organizations, including the American Roentgen Ray Society, National Association of University Radiologists, International Digital Mammography Development Group, and the Radiological Society of North America.

Dr. Conant has also been recognized for her outstanding contributions to the field of breast imaging by Philadelphia Magazine, America’s Top Doctors, and Best Doctors in America. She has been a featured expert in the national media, including appearances on Good Morning America, CBS News, USA Today, The New York Times, and Redbook.

Nancy M. Cappello, PhD, Moderator
Dr.  Cappello, PhD is Director and Founder of Are You Dense, Inc., and Are You Dense Advocacy, Inc., with a mission to educate the public about the risks and screening challenges of dense breast tissue to prevent missed, delayed, and advanced-stage cancer, thus reducing mortality. She is the inspiration behind Connecticut’s first-in-the-nation density reporting law passed in 2009, making the state a global leader in density reporting, adjunct screening, and the density reporting grassroots movement. More than half the states have since enacted density reporting laws, and a federal bill is pending.

Dr. Cappello has presented her inspiring story of patient-turned-advocate across the United States and at Scientific Forums in Rome, Tokyo, Paris, Puerto Rico, and Brisbane, Australia.  Her blog, Nancy’s Chalkboard, is published by the Huffington Post and other media outlets. She is the recipient of numerous honors and awards, including being named a Health Hero by Parade Magazine, honored by the Connecticut Women’s Hall of Fame, and selected to receive the prestigious national Americanism award by UNICO.

Dr. Cappello holds a BA and MS in Elementary and Special Education from Central Connecticut State University, a Sixth Year Degree in Administration and Supervision from Southern Connecticut State University, and a PhD in Education Administration from the University of Connecticut. When her mission is finished, she looks forward to rescuing a dog, learning Italian, and taking golf lessons.

Disclosure Information
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for anyone in a position to control content will be disclosed to participants prior to the start of each activity.

DaCarla M. Albright, MD, has reported no conflicts of interest related to the content of this activity.

Emily F. Conant, MD, has received contracted research funding and consulting fees and from Hologic and received contracted research funding from iCAD.

Nancy M. Cappello, PhD, has reported no conflicts of interest related to the content of this activity.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino 
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD, CHCP
Linda McLean, MS 
Victoria Phoenix, BS           
Jan Schultz, MSN, RN, CHCP
Judi Smelker-Mitchek, MBA, MSN, RN      
                       

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 X10


Jointly provided by

               
 

This activity is supported by an independent educational grant from Hologic, Inc.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.